Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Ceftriaxone/Metronidazole in Complicated Intra-abdominal Infections
NCT00769171Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2005
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of moxifloxacin in Intra-abdominal infection (IAI), sponsored by Bayer. Started Oct 2005; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00769171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769171.